Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate the sleep quality, anxiety and depression levels in women with mastalgia using internationally validated scales. Additionally the investigators aim to question the amount and frequency of consumption of nutritional elements which are known to aggravate mastalgia. Finally by combining and analyzing the information gathered, the investigators intend to set light to the etiopathologic and clinic aspects of mastalgia.


Clinical Trial Description

Mastalgia is encountered in 70% of premenopausal women and is one of the most frequent reasons for attending general surgery clinics. In most of the cases no physical cause is demonstrated and the etiopathogenesis is still not yet determined. In 1949 Patey, for the first time, proposed that mastalgia might be a psychologically based problem. In the following years, research was focused in this issue and some articles were published demonstrating the relationship of anxiety, depression and high stress levels with mastalgia. The efforts for finding out the etiopathologic mechanism and defining the risk factors revealed that smoking and consumption of tea, coffee and carbonated beverages in particular worsen mastalgia whereas essential fatty acids (especially gamma linoleic acid) provides a symptomatic relief. Additionally it is known that sleep irregularities cause serious deterioration in daily life quality as well as can exaggerate some medical, neurologic and/or psychiatric conditions. More than half of the population experience sleep irregularities from time to time and chronic sleep disturbances effect 20% of adult population in western countries. Therefore sleep irregularities might have contributing effects in the etiopathogenesis and/or symptomatology of therapy resistant conditions like mastalgia. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04690218
Study type Observational
Source Nigde Omer Halisdemir University
Contact
Status Completed
Phase
Start date January 1, 2021
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT02515253 - A Breast Support Intervention for Women With Breast Pain N/A
Recruiting NCT05548374 - Acupuncture for Breast Pain N/A
Terminated NCT01870687 - Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS Phase 3
Completed NCT02810236 - Focal Breast Pain: Does a Normal Ultrasound Provide Reassurance? N/A